GSK Extends Contract with Genpact
From ValueWalk
January 16, 2013 - 9:23am
GlaxoSmithKline plc (NYSE:GSK), one of the leading pharmaceutical companies worldwide, extended the contract of Genpact Limited (NYSE:G) for five more years, to provide finance and accounting services.
…
Under the agreement, Genpact Limited (NYSE:G) will continue to provide business process managementThe post GSK Extends Contract with Genpact appeared first on ValueWalk.
Continue reading this article »Share This Article: